phase readout
saveNCT06253494: Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Endometrial Cancer, Cancer of Endometrium, Carcinoma of Endometrium, Endometrial Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that